← Back to Clinical Trials
Recruiting NCT07246954

NCT07246954 A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07246954
Status Recruiting
Phase —
Sponsor M.D. Anderson Cancer Center
Condition Spiritual Care
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-12-22
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Peace InterventionUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-12-22 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To examine the feasibility and acceptability of chaplain-clinician led spiritual care (PEACE: Perception, Exploring, Addressing, Compassionate Connection, Embracing) intervention in patients with advanced cancer.

Eligibility Criteria

Eligibility Criteria 1. Participants with advanced cancer (locally advanced, metastatic, recurrent, or incurable) seen by the participant supportive/palliative care mobile team at MD Anderson Cancer Center. 2. Respond "somewhat to A great deal" to the question in the RBEC questionnaire "I will accept every possible medical treatment because my faith tells me to do everything I can to stay alive longer". 3. Participant s aged 18 years or over. 4. Karnofsky performance status ≥30% at time of inclusion into study. 5. Normal cognitive status as determined by the supportive care clinicians based on the ability to understand the nature of the study and consent process. 6. Only English-speaking, as determined by their ability to understand the informed consent, the intervention, and the assessment tools.

Contact & Investigator

Central Contact

Marvin Delgado Guay, MD

✉ marvin.delgado@mdanderson.org

📞 713-745-8190

Principal Investigator

Marvin Delgado Guay, MD

PRINCIPAL INVESTIGATOR

M.D. Anderson Cancer Center

Frequently Asked Questions

Who can join the NCT07246954 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spiritual Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07246954 currently recruiting?

Yes, NCT07246954 is actively recruiting participants. Contact the research team at marvin.delgado@mdanderson.org for enrollment information.

Where is the NCT07246954 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT07246954 clinical trial?

NCT07246954 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Marvin Delgado Guay, MD at M.D. Anderson Cancer Center. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology